Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianzhi Cheng

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nucleic Acids Research|June 3, 2024
Modular CRISPR/Cas12a synergistic activation platform for detection and logic operationsMinghao Hu, Xianzhi Cheng, Tongbo Wu
Small (Weinheim an Der Bergstrasse, Germany)|April 27, 2024
Time-Controlled Authentication Strategies for Molecular Information TransferMinghao Hu, Mengyao Yang, Xianzhi Cheng, et al.
Oncology Reports|February 11, 2025
Protein regulator of cytokinesis 1 regulates autophagy in hepatitis B virus‑associated liver cancer developmentJingjing Huang, Xianzhi Cheng, Chuang Wang, et al.
Surgical Infections|October 27, 2023
Risk Factors for Post-Operative Multi-Drug-Resistant Organism Bacterial Infection in Patients With Stanford Acute Type A Aortic DissectionJing Liang, Xianzhi Cheng, Jingyu Shao, et al.
Chemical Communications (Cambridge, England)|April 8, 2025
A multi-functional synergistic platform of Cas12a split dsDNA activatorsXiaolong Li, Jiarun Wang, Xianzhi Cheng, et al.
The American Surgeon|May 11, 2026
Risk Factors for the Progression of Pyogenic Liver Abscess to Sepsis and Development of a Predictive ModelXianzhi Cheng, Jingxin Wang, Hong Zhang, et al.
Frontiers in Microbiology|June 11, 2026
Sequential eradication of bacterial persisters: integrating phytochemical pharmacology with microenvironment-responsive delivery strategiesJixiang Bai, Lei Han, Xianzhi Cheng, et al.
Molecular Medicine Reports|August 2, 2018
UNBS5162 inhibits proliferation of human melanoma cells by inducing apoptosis via the PI3K/Akt pathwayXueli Shi, Liu Yang, Jun Xie, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nucleic Acids Research|June 3, 2024
Modular CRISPR/Cas12a synergistic activation platform for detection and logic operationsMinghao Hu, Xianzhi Cheng, Tongbo Wu
Small (Weinheim an Der Bergstrasse, Germany)|April 27, 2024
Time-Controlled Authentication Strategies for Molecular Information TransferMinghao Hu, Mengyao Yang, Xianzhi Cheng, et al.
Oncology Reports|February 11, 2025
Protein regulator of cytokinesis 1 regulates autophagy in hepatitis B virus‑associated liver cancer developmentJingjing Huang, Xianzhi Cheng, Chuang Wang, et al.
Surgical Infections|October 27, 2023
Risk Factors for Post-Operative Multi-Drug-Resistant Organism Bacterial Infection in Patients With Stanford Acute Type A Aortic DissectionJing Liang, Xianzhi Cheng, Jingyu Shao, et al.
Chemical Communications (Cambridge, England)|April 8, 2025
A multi-functional synergistic platform of Cas12a split dsDNA activatorsXiaolong Li, Jiarun Wang, Xianzhi Cheng, et al.
The American Surgeon|May 11, 2026
Risk Factors for the Progression of Pyogenic Liver Abscess to Sepsis and Development of a Predictive ModelXianzhi Cheng, Jingxin Wang, Hong Zhang, et al.
Frontiers in Microbiology|June 11, 2026
Sequential eradication of bacterial persisters: integrating phytochemical pharmacology with microenvironment-responsive delivery strategiesJixiang Bai, Lei Han, Xianzhi Cheng, et al.
Molecular Medicine Reports|August 2, 2018
UNBS5162 inhibits proliferation of human melanoma cells by inducing apoptosis via the PI3K/Akt pathwayXueli Shi, Liu Yang, Jun Xie, et al.
Pageof 1